Luc Baeyens

Luc Baeyens

Auto-generated profile, based on publicly available information

Luc Baeyens

Vrije Universiteit Brussel

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2004 in Diabetologia
Verified
Journal Article
Closed access
PDF file
LBL. Baeyens
L. Baeyens
SBS. De Breuck
S. De Breuck
JLJ. Lardon
J. Lardon
JMJ. K. Mfopou
J. K. Mfopou
IRIlse Rooman
Ilse Rooman
LBL. Bouwens
L. Bouwens

17 November 2013 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
LBLuc Baeyens
Luc Baeyens
MLMarie Lemper
Marie Lemper
GLGunter Leuckx
Gunter Leuckx
SGSofie De Groef
Sofie De Groef
PBPaola Bonfanti
Paola Bonfanti
HHHarry Heimberg
Harry Heimberg

1 October 2012 in Cell Metabolism
Verified
Journal Article
Closed access
JHJakob Bondo Hansen
Jakob Bondo Hansen
MTMorten Fog Tonnesen
Morten Fog Tonnesen
AMAndreas Nygaard Madsen
Andreas Nygaard Madsen
PHPeter H. Hagedorn
Peter H. Hagedorn
JFJosefine Friberg
Josefine Friberg
TMThomas Mandrup-Poulsen
Thomas Mandrup-Poulsen

7 March 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
MCMark Van De Casteele
Mark Van De Casteele
GLG Leuckx
G Leuckx
LBL Baeyens
L Baeyens
YCY Cai
Y Cai
YYY Yuchi
Y Yuchi
HHH Heimberg
H Heimberg
We previously showed that injury by partial duct ligation (PDL) in adult mouse pancreas activates Neurogenin 3 (Ngn3)+ progenitor cells that can differentiate to β cells ex vivo. Here we evaluate the role of Ngn3+ cells in β cell expansion in situ. PDL not only induced doubling of the β cell volume but also increased the total number of islets. β cells proliferated without extended delay (the so-called ‘refractory’ period), their proliferation potential was highest in small islets, and 86% of the β cell expansion was attributable to proliferation of pre-existing β cells. At sufficiently high Ngn3 expression level, upto 14% of all β cells and 40% of small islet β cells derived from non-β cells. Moreover, β cell proliferation was blunted by a selective ablation of Ngn3+ cells but not by conditional knockout of Ngn3 in pre-existing β cells supporting a key role for Ngn3+ insulin− cells in β cell proliferation and expansion. We conclude that Ngn3+ cell-dependent proliferation of pre-existing and newly-formed β cells as well as reprogramming of non-β cells contribute to in vivo β cell expansion in the injured pancreas of adult mice.

1 July 2010 in Contrast Media & Molecular Imaging
Verified
Journal Article
Closed access
PDF file
IWInneke Willekens
Inneke Willekens
NBNico Buls
Nico Buls
TLTony Lahoutte
Tony Lahoutte
LBLuc Baeyens
Luc Baeyens
CVChristian Vanhove
Christian Vanhove
JMJohan de Mey
Johan de Mey

5 December 2014 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
MLM Lemper
M Lemper
GLG Leuckx
G Leuckx
YHY Heremans
Y Heremans
MGM S German
M S German
HHH Heimberg
H Heimberg
LBL Baeyens
L Baeyens
Rodent acinar cells exhibit a remarkable plasticity as they can transdifferentiate to duct-, hepatocyte- and islet β-like cells. We evaluated whether exocrine cells from adult human pancreas can similarly respond to proendocrine stimuli. Exocrine cells from adult human pancreas were transduced directly with lentiviruses expressing activated MAPK (mitogen-activated protein kinase) and STAT3 (signal transducer and activator of transcription 3) and cultured as monolayers or as 3D structures. Expression of STAT3 and MAPK in human exocrine cells activated expression of the proendocrine factor neurogenin 3 in 50% to 80% of transduced exocrine cells. However, the number of insulin-positive cells increased only in the exocrine cells grown initially in suspension before 3D culture. Lineage tracing identified human acinar cells as the source of Ngn3- and insulin-expressing cells. Long-term engraftment into immunocompromised mice increased the efficiency of reprogramming to insulin-positive cells. Our data demonstrate that exocrine cells from human pancreas can be reprogrammed to transplantable insulin-producing cells that acquire functionality. Given the large number of exocrine cells in a donor pancreas, this approach presents a novel strategy to expand cell therapy in type 1 diabetes.